NanoViricides Inc. (NNVC)

[Ubertino]

NNVC deja vu for HCV-Cide:

The Quest: $84,000 Miracle Cure Costs Less Than $150 to Make

By Christine Gorman | April 23, 2014

What are the likely manufacturing costs for sofosbuvir (Brand name: Sovaldi), the newly approved miracle drug that cures hepatitis C at a cost of $84,000 for the full 12-week course of treatment? Anywhere from $68 to $136 for the full course, according to an analysis that was published in Clinical Infectious Disease (CID) in January—which was about a month after Gilead announced how much it was planning to charge for the drug.

No wonder the pharmaceutical company has just broken the record for “sales of a drug in its first full quarter on the market,” according to Andrew Pollack of the New York Times. Indeed, Pollack calculated that the $2.3 billion first quarter sofosbuvir sales also broke the record for the first full year of any drug. (For the record, the previous record was $1.56 billion for another hepatitis C drug, telaprevir, brand name: Incivek.)

http://blogs.scientificamerican.com/observations/2014/04/23/the-quest-84000-sovaldimiracle-cure-costs-less-than-150-to-make/

(s&c)